Using its proprietary drug delivery technologies, SkyePharma develops new formulations of existing pharmaceutical products as well as new chemical entities to provide a clinical benefit to patients.
|
There are two approved products in the area of inhalation drug delivery that incorporate the Group’s proven proprietary technologies. The Group’s products are marketed in a number of countries throughout the world by leading and speciality pharmaceutical companies. |
![]() |